Northwest Biotherapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly The Latest Pharma Company To Sign

Patients with glioblastoma can expect to live a median eight months after diagnosis, but two anticipated launches in 2024 and a rich development pipeline could improve that bleak clinical outlook. “Th

The US may be in Thanksgiving mode, but companies in other parts of the world continue to come forward with venture capital investment news, including China's Alphamab Oncology with a $100m Series A

Cancer vaccine research has had its fair share of disappointing clinical trial results, but a central European company, Sotio AS , owned by the international finance group, PPF Group, presented posit